First-line diuretics versus other classes of antihypertensive drugs for hypertension
Author:
Affiliation:
1. Department of Anesthesiology, Pharmacology & Therapeutics; University of British Columbia; Vancouver Canada
Publisher
Wiley
Subject
Pharmacology (medical)
Reference204 articles.
1. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT);ALLHAT Group;Hypertension,2003
2. Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT STUDY;Bang;Journal of the American College of Cardiology,2015
3. Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study;Barzilay;Journal of Clinical Hypertension,2004
4. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT);Barzilay;Archives of Internal Medicine,2006
5. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT);Barzilay;Diabetes Care,2001
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Automated non-invasive laser speckle imaging of the chick heart rate and extraembryonic blood vessels and their response to nifedipine and amlodipine drugs;2024-08-27
2. How do first-line diuretics compare with other classes of antihypertensive drugs for adults with hypertension?;Cochrane Clinical Answers;2024-07-05
3. Diuretics use in the management of hypertension;Hipertensión y Riesgo Vascular;2024-07
4. Clinical features, laboratory findings and treatment of juxtaglomerular cell tumors: a systemic review;Hypertension Research;2024-03-04
5. Un repaso a las novedades en hipertensión 2023: morbimortalidad, objetivos, fármacos y alcohol 0,0;Actualización en Medicina de Familia;2024-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3